Dr. Julie Brahmer believes that people with mesothelioma have reasons to be hopeful. She continues to be optimistic about new treatment agents that have emerged and have significantly benefitted patients.
Dr. Julie Brahmer works to accelerate the diagnosis and treatment of mesothelioma and to prevent the disease altogether.
Advancements in Mesothelioma Treatment and Research
Dr. Brahmer collaborates on mesothelioma clinical trials to advance treatment options for the disease. She serves as program director for Johns Hopkins Clinical Research Network and works with trial sponsors to support mesothelioma research.
Dr. Brahmer practices an evidence-based, multidisciplinary approach to care. She meets weekly with a group of cancer specialists to discuss patient treatment and prognosis. She remains dedicated to her clinical and academic work to accelerate the diagnosis and treatment of mesothelioma and to prevent the disease altogether.